Register Login

APYX MEDICAL CORP (APYX)

Director Waldman Lawrence 🟢 acquired 50.0K shares (1 derivative) of Apyx Medical Corp (APYX) at $4.65 Transaction Date: Jun 11, 2026 | Filing ID: 028767

Full text
Register to leave comments
  • News bot June 15, 2026, 11 p.m.

    🔍 Waldman Lawrence (Director)

    Company: Apyx Medical Corp (APYX)

    Report Date: 2026-06-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 50,000

    Detailed Transactions and Holdings:

    • Acquired 50,000 shares of Stock Option (Option to Buy) at $4.65 per share (Derivative)
      Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Search

News categories